Profile | GDS4284 / 229871_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2585.35 | 87 |
GSM687648 | Patient 402 control | 3656.84 | 91 |
GSM687653 | Patient 403 control | 3464.52 | 90 |
GSM687658 | Patient 404 control | 3608.86 | 90 |
GSM687663 | Patient 411 control | 4247.47 | 92 |
GSM687668 | Patient 422 control | 3508.29 | 90 |
GSM687673 | Patient 424 control | 3765.84 | 91 |
GSM687678 | Patient 425 control | 5447.48 | 94 |
GSM687683 | Patient 427 control | 3761.79 | 91 |
GSM687688 | Patient 428 control | 3534.9 | 90 |
GSM687695 | Patient 441 control | 3157.32 | 90 |
GSM687699 | Patient 443 control | 3646.66 | 91 |
GSM687704 | Patient 444 control | 6773.12 | 95 |
GSM687707 | Patient 448 control | 4102.69 | 92 |
GSM687712 | Patient 449 control | 3566.05 | 90 |
GSM687719 | Patient 450 control | 3728.71 | 91 |
GSM687724 | Patient 451 control | 4901.52 | 93 |
GSM687728 | Patient 452 control | 4867.14 | 93 |
GSM687646 | Patient 401 treated 24h | 2912 | 88 |
GSM687649 | Patient 402 treated 24h | 3435.39 | 90 |
GSM687665 | Patient 411 treated 24h | 3838.83 | 91 |
GSM687651 | Patient 402 treated 4 weeks | 3740.64 | 91 |
GSM687667 | Patient 411 treated 4 weeks | 4009.39 | 92 |
GSM687670 | Patient 422 treated 24h | 3413.58 | 90 |
GSM687671 | Patient 422 treated 4 weeks | 3490.32 | 90 |
GSM687654 | Patient 403 treated 24h | 3099.22 | 89 |
GSM687675 | Patient 424 treated 24h | 2837.89 | 88 |
GSM687685 | Patient 427 treated 24h | 4809.83 | 93 |
GSM687656 | Patient 403 treated 4 weeks | 3180.04 | 89 |
GSM687677 | Patient 424 treated 4 weeks | 4424.11 | 92 |
GSM687687 | Patient 427 treated 4 weeks | 3873.31 | 91 |
GSM687692 | Patient 428 treated 4h | 3773.63 | 91 |
GSM687716 | Patient 449 treated 4h | 4235.25 | 92 |
GSM687722 | Patient 450 treated 4h | 3658.3 | 91 |
GSM687680 | Patient 425 treated 24h | 5315.59 | 94 |
GSM687690 | Patient 428 treated 24h | 3233.77 | 89 |
GSM687700 | Patient 443 treated 24h | 3028.44 | 89 |
GSM687705 | Patient 444 treated 24h | 5786.78 | 94 |
GSM687714 | Patient 449 treated 24h | 3758.42 | 91 |
GSM687721 | Patient 450 treated 24h | 3282.06 | 90 |
GSM687682 | Patient 425 treated 4 weeks | 5769.77 | 94 |
GSM687694 | Patient 428 treated 4 weeks | 3949.4 | 91 |
GSM687702 | Patient 443 treated 4 weeks | 2760.95 | 88 |
GSM687718 | Patient 449 treated 4 weeks | 3585.35 | 91 |
GSM687723 | Patient 450 treated 4 weeks | 3789.96 | 91 |
GSM687661 | Patient 404 treated 4h | 3561.27 | 90 |
GSM687710 | Patient 448 treated 4h | 3816.71 | 91 |
GSM687726 | Patient 451 treated 4h | 5542.36 | 94 |
GSM687730 | Patient 452 treated 4h | 3399.66 | 91 |
GSM687660 | Patient 404 treated 24h | 2917.31 | 89 |
GSM687697 | Patient 441 treated 24h | 3621.1 | 91 |
GSM687709 | Patient 448 treated 24h | 2928.21 | 88 |
GSM687725 | Patient 451 treated 24h | 5240.57 | 94 |
GSM687729 | Patient 452 treated 24h | 3349.59 | 90 |
GSM687727 | Patient 451 treated 4 weeks | 7709.98 | 96 |
GSM687731 | Patient 452 treated 4 weeks | 3828.75 | 91 |